These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35709874)

  • 1. Allosteric regulation of the inactive to active state conformational transition in CDPK1 protein of Plasmodium falciparum.
    Gupta P; Mohanty D
    Int J Biol Macromol; 2022 Aug; 215():489-500. PubMed ID: 35709874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the regulation of malarial calcium-dependent protein kinase 1.
    Ahmed A; Gaadhe K; Sharma GP; Kumar N; Neculai M; Hui R; Mohanty D; Sharma P
    FASEB J; 2012 Aug; 26(8):3212-21. PubMed ID: 22539638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) and its role in microneme secretion during erythrocyte invasion.
    Bansal A; Singh S; More KR; Hans D; Nangalia K; Yogavel M; Sharma A; Chitnis CE
    J Biol Chem; 2013 Jan; 288(3):1590-602. PubMed ID: 23204525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations and biochemical characterization of Pf14-3-3 and PfCDPK1 interaction towards its role in growth of human malaria parasite.
    Jain R; Dey P; Gupta S; Pati S; Bhattacherjee A; Munde M; Singh S
    Biochem J; 2020 Jun; 477(12):2153-2177. PubMed ID: 32484216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.
    Gaji RY; Checkley L; Reese ML; Ferdig MT; Arrizabalaga G
    Antimicrob Agents Chemother; 2014 May; 58(5):2598-607. PubMed ID: 24550330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.
    Ansell KH; Jones HM; Whalley D; Hearn A; Taylor DL; Patin EC; Chapman TM; Osborne SA; Wallace C; Birchall K; Large J; Bouloc N; Smiljanic-Hurley E; Clough B; Moon RW; Green JL; Holder AA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6032-43. PubMed ID: 25070106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PfCDPK1 mediated signaling in erythrocytic stages of Plasmodium falciparum.
    Kumar S; Kumar M; Ekka R; Dvorin JD; Paul AS; Madugundu AK; Gilberger T; Gowda H; Duraisingh MT; Keshava Prasad TS; Sharma P
    Nat Commun; 2017 Jul; 8(1):63. PubMed ID: 28680058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Plasmodium falciparum CDPK1 by conditional expression of its J-domain demonstrates a key role in schizont development.
    Azevedo MF; Sanders PR; Krejany E; Nie CQ; Fu P; Bach LA; Wunderlich G; Crabb BS; Gilson PR
    Biochem J; 2013 Jun; 452(3):433-41. PubMed ID: 23548171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.
    Flaherty BR; Ho TG; Schmidt SH; Herberg FW; Peterson DS; Kennedy EJ
    ACS Infect Dis; 2019 Apr; 5(4):506-514. PubMed ID: 30746930
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bansal A; Molina-Cruz A; Brzostowski J; Liu P; Luo Y; Gunalan K; Li Y; Ribeiro JMC; Miller LH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):774-779. PubMed ID: 29311293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.
    Bansal A; Ojo KK; Mu J; Maly DJ; Van Voorhis WC; Miller LH
    mBio; 2016 Dec; 7(6):. PubMed ID: 27923926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of allosteric inhibition in the
    Byun JA; Van K; Huang J; Henning P; Franz E; Akimoto M; Herberg FW; Kim C; Melacini G
    J Biol Chem; 2020 Jun; 295(25):8480-8491. PubMed ID: 32317283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
    Chapman TM; Osborne SA; Wallace C; Birchall K; Bouloc N; Jones HM; Ansell KH; Taylor DL; Clough B; Green JL; Holder AA
    J Med Chem; 2014 Apr; 57(8):3570-87. PubMed ID: 24689770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase from Plasmodium falciparum: Structural and kinetic insights into the allosteric mechanism.
    Zhong W; Li K; Cai Q; Guo J; Yuan M; Wong YH; Walkinshaw MD; Fothergill-Gilmore LA; Michels PAM; Dedon PC; Lescar J
    Biochem Biophys Res Commun; 2020 Nov; 532(3):370-376. PubMed ID: 32878705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cGMP Binding Domain D Mediates a Unique Activation Mechanism in Plasmodium falciparum PKG.
    Franz E; Knape MJ; Herberg FW
    ACS Infect Dis; 2018 Mar; 4(3):415-423. PubMed ID: 29251493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing Computational Approaches Towards Identifying Malarial Allosteric Modulators: A Case Study of
    Amusengeri A; Astl L; Lobb K; Verkhivker GM; Tastan Bishop Ö
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Design of Novel Allosteric Inhibitors for
    Shehzad S; Pandey R; Malhotra P; Gupta D
    Molecules; 2021 May; 26(9):. PubMed ID: 34066964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamical Basis of Allosteric Activation for the
    Huang J; Byun JA; VanSchouwen B; Henning P; Herberg FW; Kim C; Melacini G
    J Phys Chem B; 2021 Jun; 125(24):6532-6542. PubMed ID: 34115498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib.
    Yan M; Wang H; Wang Q; Zhang Z; Zhang C
    Phys Chem Chem Phys; 2016 Apr; 18(15):10367-74. PubMed ID: 27029952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.